These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 349098)

  • 21. Characteristics of biliary excretion of cefazolin and other cephalosporins with reference to the relationship between serum levels and administration conditions.
    Nishida M; Murakawa T; Matsubara T; Kohno Y; Yokota Y
    Chemotherapy; 1976; 22(1):30-6. PubMed ID: 1253628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The cephalosporins and their clinical value].
    Tauchnitz C
    Z Gesamte Inn Med; 1976 Oct; 31(20):828-34. PubMed ID: 1051781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of cephalothin, cephaloridine and cefazolin to human serum proteins.
    Miyake Y; Ebata M
    J Antibiot (Tokyo); 1976 Jun; 29(6):667. PubMed ID: 950323
    [No Abstract]   [Full Text] [Related]  

  • 24. Human serum protein binding of cephalosporin antibiotics in vitro.
    Singhvi SM; Heald AF; Gadebusch HH; Resnick ME; Difazio LT; Leitz MA
    J Lab Clin Med; 1977 Feb; 89(2):414-20. PubMed ID: 833477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cefamandole in patients with renal impairment.
    Czerwinski AW; Pederson JA
    Antimicrob Agents Chemother; 1979 Feb; 15(2):161-4. PubMed ID: 426510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
    Concia E; Marone P; Verani D; Marino P
    Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus.
    Regamey C; Libke RD; Engelking ER; Clarke JT; Kirby MM
    J Infect Dis; 1975 Mar; 131(3):291-4. PubMed ID: 1039311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo comparative evaluations of injectable cephalosporin derivatives and ampicillin.
    Gotô S; Kuwahara S
    Chemotherapy; 1976; 22(5):286-96. PubMed ID: 1047636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cephalosporin pharmacokinetics in rabbits].
    Klimova VS; Rudzit EA; Iakovlev VP
    Antibiotiki; 1981 Apr; 26(4):284-7. PubMed ID: 7235668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacology of cefamandole in patients with reduced renal function.
    Czerwinski AW; Pederson JA
    Scand J Infect Dis Suppl; 1980; suppl 25():45-8. PubMed ID: 6937951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study of 7 cephalosporins on "Staphylococcus aureus" by the method of population analysis (author's transl)].
    Sirot D; Sirot J; Cluzel R; Joly B
    Pathol Biol (Paris); 1977 Nov; 25(9):605-10. PubMed ID: 341049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin.
    Regamey C; Libke RD; Clarke JT; Kirby WM
    Infection; 1974; 2(3):132-6. PubMed ID: 4415038
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of piperonyl butoxide on cephalosporin nephrotoxicity in the rabbit. An effect on cephaloridine transport.
    Tune BM; Kuo CH; Hook JB; Hsu CY; Fravert D
    J Pharmacol Exp Ther; 1983 Mar; 224(3):520-4. PubMed ID: 6827476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of five cephalosporins in healthy male volunteers.
    Paradelis AG; Stathopoulos G; Trianthaphyllidis C; Logaras G
    Arzneimittelforschung; 1977; 27(11):2167-70. PubMed ID: 580023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics. Part 3: cephalosporins.
    Barza M; Miao PV
    Am J Hosp Pharm; 1977 Jun; 34(6):621-9. PubMed ID: 327800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages.
    Rylander M; Holm SE; Norrby R; Brorson JE
    Scand J Infect Dis Suppl; 1978; (13):52-7. PubMed ID: 278147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal handling and lymph concentration of two cephalosporin analogues, cephacetrile and cephaloridine: an experimental study in dogs.
    Naber KG; Madsen PO
    Antimicrob Agents Chemother; 1973 Jan; 3(1):81-6. PubMed ID: 4790578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease.
    Ratzan KR; Ruiz C; Irvin GL
    Antimicrob Agents Chemother; 1974 Oct; 6(4):426-31. PubMed ID: 4157339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ascitic fluid cephalosporin concentrations: influence of protein binding and serum pharmacokinetics.
    Gerding DN; Peterson LR; Legler DC; Hall WH; Schierl EA
    Antimicrob Agents Chemother; 1978 Aug; 14(2):234-9. PubMed ID: 697350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cephalosporin antibiotics in therapy of experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis in rabbits.
    Sande MA; Sherertz RJ; Zak O; Strausbaugh LJ
    J Infect Dis; 1978 May; 137 Suppl():S161-S168. PubMed ID: 649999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.